Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease
Takudzwa Mkorombindo, Mark T DransfieldLung Health Center, Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USAAbstract: Despite maximal medical therapy, a subset of patients with chronic obstructive pulmonary dis...
Main Authors: | Mkorombindo T, Dransfield MT |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-08-01
|
Series: | International Journal of COPD |
Subjects: | |
Online Access: | https://www.dovepress.com/mepolizumab-in-the-treatment-of-eosinophilic-chronic-obstructive-pulmo-peer-reviewed-article-COPD |
Similar Items
-
Reassessing the Role of Eosinophils as a Biomarker in Chronic Obstructive Pulmonary Disease
by: Mariaenrica Tinè, et al.
Published: (2019-07-01) -
Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma
by: Haldar P
Published: (2017-06-01) -
Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
by: Steven W. Yancey, et al.
Published: (2019-09-01) -
The Association Between Eosinophil Variability Patterns and the Efficacy of Inhaled Corticosteroids in Stable COPD Patients
by: Yoon JK, et al.
Published: (2020-08-01) -
Blood Eosinophil and Risk of Exacerbation in Chronic Obstructive Pulmonary Disease Patients: A Retrospective Cohort Analysis
by: Chan MC, et al.
Published: (2020-11-01)